Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Eric L Sievers

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 16, 2021
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies.

Stephen M Ansell, Michael B Maris, Alexander M Lesokhin

Pageof 1

Frequent Collaborators

1 joint publications

Stephen M Ansell

1 joint publications

Ian W Flinn

1 joint publications

Diego Villa

1 joint publications

Matthew G Mei

1 joint publications

Oleg E Akilov

1 joint publications

Lisa D S Johnson

Frequent Collaborators

1 joint publications

Stephen M Ansell

1 joint publications

Ian W Flinn

1 joint publications

Diego Villa

1 joint publications

Matthew G Mei

Top Related Videos

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on : May 17, 2019

9.5K
See more related videos

Top Related Videos

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on : May 17, 2019

9.5K
See more related videos